Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

3359 - Cancer patient attitudes and preferences towards smoking status assessment


10 Sep 2017


Poster display session


Lawson Eng


Annals of Oncology (2017) 28 (suppl_5): v543-v567. 10.1093/annonc/mdx388


L. Eng1, S. Liu1, Q. Zhang2, D. Farzanfar3, R. Milne4, S. Yeung3, C.M. Brown3, D. Howell2, W. Xu5, D.P. Goldstein6, J.M. Jones3, P. Selby7, M.E. Giuliani4, G. Liu3

Author affiliations

  • 1 Department Of Medical Oncology And Hematology, Princess Margaret Cancer Centre, University of Toronto, M5G 2M9 - Toronto/CA
  • 2 Department Of Biostatistics, Princess Margaret Cancer Centre, M5G 2M9 - Toronto/CA
  • 3 Department Of Medical Oncology And Hematology, Princess Margaret Hospital, M5G 2M9 - Toronto/CA
  • 4 Department Of Radiation Oncology, Princess Margaret Cancer Centre, M5G 2M9 - Toronto/CA
  • 5 Department Of Biostatistics, Ontario Cancer Institute, Princess Margaret Cancer Centre, University of Toronto, Toronto/CA
  • 6 Otolaryngology-head And Neck Surgery, Princess Margaret Cancer Centre, M5G 2M9 - Toronto/CA
  • 7 Addictions, Centre for Addiction and Mental Health, M6J 1H4 - Toronto/CA


Abstract 3359


Continued smoking after a cancer diagnosis is associated with poorer outcomes. As smoking cessation is an important part of cancer care, understanding cancer patient (pt) attitudes towards smoking status assessment will help with integrating smoking cessation programs into cancer care.


Cancer pts from all subtypes were surveyed on their smoking history, assessment rates and attitudes/preferences towards smoking status assessment. Multivariate logistic regression models helped assess for factors associated with screening preferences.


Among 501 pts, 115 smoked at diagnosis and 60% quit after; 53% had a tobacco related (lung/head and neck) cancer (TRC); 64% were treated curatively; 40% reported that their smoking status was assessed only on their first clinic visit, while 32% were assessed at a few visits and 12% all visits. Most felt that smoking status should be assessed at the first visit (95%), while half (58%) felt it should be assessed every visit. Most felt comfortable with being assessed (96%), felt it was important for clinicians to be aware of smoking status (98%) and that smoking cessation discussions should occur at the first visit (87%). Most preferred being assessed by their oncologist (88%); less than half preferred being asked by another healthcare provider (44%), on paper (29%) or electronic surveys (32%). When compared to ex/never smokers, current smokers were assessed more often at every/most visits (36% vs 20% P = 0.001); fewer felt assessment should occur at the first visit (89% vs 97% P = 0.008) and were less comfortable with being assessed (88% vs 98% P 


Most cancer pts felt that assessment of smoking status was important, were comfortable with being assessed and preferred being assessed directly by their oncologist. Routine screening of those currently smoking is recommended to help with cessation.

Clinical trial identification

Legal entity responsible for the study

Princess Margaret Cancer Centre




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.